[1] |
BRAY F, LAVERSANNE M, SUNG H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263.
|
[2] |
HAN B F, ZHENG R S, ZENG H M, et al. Cancer incidence and mortality in China, 2022[J]. J Natl Cancer Cent, 2024, 4(1): 47-53.
|
[3] |
顾凯, 庞怡, 吴春晓, 等. 2017年上海市恶性肿瘤发病和死亡情况与2002—2017年的变化趋势分析[J]. 肿瘤, 2023, 43(4): 241-256.
|
|
GU K, PANG Y, WU C X, et al. Analysis of the current status of cancer incidence and mortality in Shanghai, 2017 and trends of 2002-2017[J]. Tumor, 2023, 43(4): 241-256.
|
[4] |
吴春晓, 顾凯, 庞怡, 等. 2002—2013年上海市恶性肿瘤生存分析[J]. 肿瘤, 2023, 43(4): 257-265.
|
|
WU C X, GU K, PANG Y, et al. Survival analysis of cancer cases diagnosed during 2002: 2013 in Shanghai: a population-based study[J]. Tumor, 2023, 43(4): 257-265.
|
[5] |
国家癌症中心. 中国肿瘤登记工作指导手册-2016[M]. 北京: 人民卫生出版社, 2016: 59-75.
|
|
National Cancer Center. Guideline for Chinese Cancer Registration-2016[M]. Beijing: People’s Medical Publishing House, 2016: 59-75.
|
[6] |
PARKIN D M, CHEN V W, FERLAY J, et al. Comparability and quality control in cancer registration. IARC technical report No.19[M]. Lyon: IARC Press,1994.
|
[7] |
上海市疾病预防控制中心. 上海市恶性肿瘤发病率、死亡率和生存率: 2001-2012[M]. 上海: 上海科学普及出版社, 2017: 1-6.
|
|
Shanghai Municipal Center for Disease Control and Prevention. Incidence rate, mortality and survival rate of malignant tumors in Shanghai: 2001-2012[M]. Shanghai: Shanghai Science Popularization Press, 2017: 1-6.
|
[8] |
WALKER R A. World health organization classification of tumours. pathology and genetics of tumours of the breast and female genital organs[J]. Histopathology, 2005, 46(2): 229.
|
[9] |
卢伟, 郑莹. 肿瘤命名与编码[M]. 上海: 第二军医大学出版社, 2011.
|
|
LU W, ZHENG Y. Tumor Naming and Coding[M]. Shanghai: Second Military Medical University Press, 2011.
|
[10] |
安澜, 郑荣寿, 张思维, 等. Elandt-Johnson模型推算完全寿命表方法学原理及其在中国人群寿命表中的应用[J]. 中国卫生统计, 2019, 36(5): 768-773.
|
|
AN L, ZHENG R S, ZHANG S W, et al. Methodological principle of Elandt-Johnson model for calculating complete life table and its application in China population life table[J]. Chin J Health Stat, 2019, 36(5): 768-773.
|
[11] |
ESTÈVE J, BENHAMOU E, RAYMOND L. Statistical methods in cancer research. Volume Ⅳ. Descriptive epidemiology[M]. IARC Sci Publ, 1994,128:1-302.
|
[12] |
KIM H J, FAY M P, FEUER E J, et al. Permutation tests for joinpoint regression with applications to cancer rates[J]. Stat Med, 2000, 19(3): 335-351.
doi: 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z
pmid: 10649300
|
[13] |
ESTÈVE J, BENHAMOU E, RAYMOND L. Statistical methods in cancer research, volume Ⅳ Descriptive epidemiology[M]. Lyon: International Agency for Research on Cancer, 1994. IARC Scientific Publications No. 128.
|
[14] |
ALLEMANI C, MATSUDA T, DI CARLO V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries[J]. Lancet, 2018, 391(10125): 1023-1075.
|
[15] |
莫淼, 袁晶, 周昌明, 等. 以大型单中心的医院登记为基础的3.5万例乳腺癌患者长期生存报告[J]. 中国癌症杂志, 2020, 30(2): 90-97.
|
|
MO M, YUAN J, ZHOU C M, et al. Changing long-term survival of Chinese breast cancer patients: experience from a large single institution hospital based cancer registry with 35 thousand patients[J]. China Oncol, 2020, 30(2): 90-97.
|
[16] |
ZENG H M, CHEN W Q, ZHENG R S, et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries[J]. Lancet Glob Health, 2018, 6(5): e555-e567.
|
[17] |
PHD H S, LISA A NEWMAN MD M, et al. Breast cancer statistics 2024[J]. CA A Cancer J Clin, 2024, 74(6): 477-495.
|
[18] |
吴春晓, 郑莹, 鲍萍萍, 等. 2003—2012年上海市户籍女性乳腺癌发病特征分析[J]. 中华预防医学杂志, 2017, 51(8): 692-697.
|
|
WU C X, ZHENG Y, BAO P P, et al. Analysis of the patterns of female breast cancer incidence in Shanghai, 2003-2012[J]. Chin J Prev Med, 2017, 51(8): 692-697.
|
[19] |
吴春晓, 顾凯, 王春芳, 等. 上海市女性乳腺癌流行现况、回顾与比较分析[J]. 外科理论与实践, 2019, 24(5): 421-427.
|
|
WU C X, GU K, WANG C F, et al. Incidence of female breast cancer in Shanghai: current evidence and a comparative retrospective study[J]. J Surg Concepts Pract, 2019, 24(5): 421-427.
|
[20] |
郑杨, 王春芳, 吴春晓, 等. 《“健康上海2030”规划纲要》三项主要指标解读[J]. 上海预防医学, 2018, 30(1): 11-14.
|
|
ZHENG Y, WANG C F, WU C X, et al. Interpretation of three main indicators of the “2030 plan for healthy Shanghai” [J]. Shanghai J Prev Med, 2018, 30(1): 11-14.
|
[21] |
World Health Organization. WHO position paper on mammography screening[EB/OL]. (2014-01-01)[2025-01-01]. https://www.who.int/publications/i/item/9789241507936.
|
[22] |
World Health Organization. The Global Breast Cancer Initiative[EB/OL]. (2014-01-01)[2025-01-01]. https://www.who.int/initiatives/global-breast-cancer-initiative.
|